Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma
To access this article, please choose from the options below
PII: S0959-8049(09)00777-1
doi:10.1016/j.ejca.2009.10.019
© 2009 Elsevier Ltd. All rights reserved.
